Trichinosis medical therapy: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 5: | Line 5: | ||
The mainstay of [[therapy]] for trichinosis are [[Anthelmintic|anthelmintics drugs]] such as [[albendazole]] or [[mebendazole]]. | The mainstay of [[therapy]] for trichinosis are [[Anthelmintic|anthelmintics drugs]] such as [[albendazole]] or [[mebendazole]]. | ||
==Medical | ==Medical Therapy== | ||
*Treatment for [[asymptomatic]], abortive and mild patients: | *Treatment for [[asymptomatic]], abortive and mild patients: | ||
**Administration of [[Anthelmintic|anthelmintics]] | **Administration of [[Anthelmintic|anthelmintics]] | ||
Revision as of 21:53, 29 January 2016
|
Trichinosis Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Trichinosis medical therapy On the Web |
|
American Roentgen Ray Society Images of Trichinosis medical therapy |
|
Risk calculators and risk factors for Trichinosis medical therapy |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Danitza Lukac
Overview
The mainstay of therapy for trichinosis are anthelmintics drugs such as albendazole or mebendazole.
Medical Therapy
- Treatment for asymptomatic, abortive and mild patients:
- Administration of anthelmintics
- Administration of glucocorticoids if needed.
- Treatment for pronounced and severe patients:
- Hospitalization
- Compulsory for severe cases
- Administration of glucocorticoids, anthelmintics and analgesics.
- Administration of fluids and electrolytes[1]
- Hospitalization
| Drug | Adult and Pediatric Dose |
|---|---|
| Albendazole | 400 mg twice a day by mouth for 8 to 14 days |
| Mebendazole | 200 to 400 mg three times a day by mouth for 3 days, then 400 to 500 mg three times a day by mouth for 10 days |
- Prompt treatment with antiparasitic drugs can help prevent the progression of trichinellosis by killing the adult worms and so preventing further release of larvae.
- Once the larvae have become established in skeletal muscle cells, usually by 3 to 4 weeks post infection, treatment may not completely eliminate the infection and associated symptoms.
- Treatment with either mebendazole or albendazole is recommended.
- If treatment is not initiated within the first several days of infection, more prolonged or repeated courses of treatment may be necessary.
- Both drugs are considered relatively safe but have been associated with side effects including bone marrow suppression.
- Patients on longer courses of therapy should be monitored by serial complete blood counts to detect any adverse effects promptly and discontinue treatment.
- Albendazole and mebendazole are not approved for use in pregnant women or children under the age of 2 years.
- In addition to antiparasitic medication, treatment with glucocorticoids such as prednisone may be used to relieve muscle pain associated with larval migration.[2]
References
- ↑ Gottstein B, Pozio E, Nöckler K (2009). "Epidemiology, diagnosis, treatment, and control of trichinellosis". Clin Microbiol Rev. 22 (1): 127–45, Table of Contents. doi:10.1128/CMR.00026-08. PMC 2620635. PMID 19136437.
- ↑ Trichinellosis. CDC. http://www.cdc.gov/parasites/trichinellosis/health_professionals/index.html#tx. Accessed on January 26, 2016